1
Return

Cytomegalovirus After Autologous Hematopoietic Cell Transplantation: Impact on Outcome and A Personalized Risk-adapted Prevention Strategy

delete2026-06-20
delete0
delete
OA
AI
A
Alicja Sadowska-Klasa
H
Hu Xie
L
Leona A. Holmberg
A
Alpana Waghmare
W
Wendy M. Leisenring
M
Michael J. Boeckh *
DOI：10.1016/j.jtct.2026.06.009delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• CMV-seropositive autograft recipients are at risk for CMV complications • High-risk CMV infection (≥500 IU/mL or disease) are associated with non-relapse mortality • A risk score predicts post-transplant high-risk CMV infection • A diagnostic stewardship-based surveillance strategy has been developed
Keywords:
Cytomegalovirus
autologous hematopoietic cell transplantation
non-relapse mortality

Journal

Transplantation and Cellular Therapy cover
Transplantation and Cellular Therapy
IF:
4.4
Papers:
2.1K
Citations:
4.4K

Organization

F
fred hutchinson cancer center
Scholars:
1.2K
Papers: 437
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers